One in Three German Workplace Accidents Involves Intoxicants—And the New Cannabis Rules Leave Employers in a Tight Spot

Since Germany legalized recreational cannabis in April 2024, employers face unclear workplace rules, with bans allowed on-site but not after-hours, while medical cannabis use surges 4500%.

Since Germany relaxed rules on private cannabis use in April 2024, the workplace has become a legal headache. The new law covers recreational consumption but says almost nothing about on-the-job rules. Companies must still navigate older statutes, and the uncertainty is costing them. Estimates from the Arbeiterkammer suggest that employees using intoxicants can suffer a 25% drop in performance and are absent up to 17% more often than their peers. Most starkly, statistics show that one in every three workplace accidents occurs under the influence of addictive substances.

Employers do have tools. They can ban cannabis consumption across the entire company site using the Direktionsrecht, a management right rooted in the Gewerbeordnung (Industrial Code). That ban can be embedded in employment contracts, works agreements, or internal directives. But if a works council exists, the rules must be co-determined. A blanket prohibition on after-hours use, however, is off the table—it would be a disproportionate invasion of privacy. The exception is safety-critical roles, where residual traces of consumption can still impair alertness.

Drug testing remains a minefield. Random, suspicionless checks are still illegal. Tests are only allowed on a voluntary basis or when a concrete suspicion of acute impairment exists.

Certain sectors are especially vulnerable. According to analyses from Sucht Schweiz, the highest-risk industries include hospitality, construction, transport, IT, and finance. High workloads, tight deadlines, and irregular shifts drive what experts call "functional consumption"—employees using substances to initially boost performance, often at the long-term cost of cardiovascular and mental health.

Advertisement

Prevention strategies like these require practical tools that put safety policies into action. A free Health & Safety Toolkit provides ready-to-use risk assessments, checklists, and templates that help UK employers meet their legal duties and reduce workplace hazards before they cause harm. Over 37,000 British companies already rely on these resources. Download the free Health & Safety Toolkit

Meanwhile, the medical cannabis market has exploded. Since the law change in spring 2024, the amount of cannabis dispensed has surged by roughly 4,500 percent. Germany now has over a million patients and imported around 200 tonnes in 2025, making it the world’s largest market for medical cannabis. Research is advancing too. On May 18, 2026, a Munich-based company received "Breakthrough Therapy" designation from the U.S. Food and Drug Administration for a cannabis-based painkiller targeting chronic back pain. That recognition highlights the drug’s therapeutic value—but it also raises fresh questions for employers: How do you legally handle staff who use cannabis as medicine?

Supervisors carry a duty of care for the entire workforce. If an employee is clearly impaired by cannabis, the boss must remove them from the workplace to protect both the individual and colleagues, and must also ensure the person gets home safely. In high-responsibility or high-risk jobs, a zero-tolerance threshold for psychoactive substances is usually in place. Experts recommend clear prevention strategies: training for managers, counseling services, and an open company culture. That, they argue, is the only way to minimize safety risks and productivity losses.